Literature DB >> 15614846

Counselling following a diagnosis of congenital heart disease.

Lindsey D Allan1, Ian C Huggon.   

Abstract

Counselling the parents following a diagnosis of fetal congenital heart disease (CHD) is as important a task for the fetal cardiologist, as the skill involved in achieving an accurate diagnosis. The counsellor will base prognosis not only on the diagnosis itself but also on the security of diagnosis, the stage in gestation and potential for change, the association with extracardiac malformations and the known results of treatment. Depending on the gestational age and legal situation the counsellor is operating in, termination of pregnancy may be one of the options to consider and one that should always be raised in discussion. Thus, the parents may be in the position of making a crucial decision concerning the management of the pregnancy on the basis of the information received, so it is vital that the counsellor is truly able to communicate with them, whatever be their level of understanding. 2004 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2004        PMID: 15614846     DOI: 10.1002/pd.1071

Source DB:  PubMed          Journal:  Prenat Diagn        ISSN: 0197-3851            Impact factor:   3.050


  15 in total

Review 1.  Prenatal Counseling of Fetal Congenital Heart Disease.

Authors:  Caroline K Lee
Journal:  Curr Treat Options Cardiovasc Med       Date:  2017-01

Review 2.  The impact of fetal echocardiography on the prevalence of liveborn congenital heart disease.

Authors:  Ioannis Germanakis; Stavros Sifakis
Journal:  Pediatr Cardiol       Date:  2006-07-06       Impact factor: 1.655

3.  Prenatal diagnosis of hypoplastic left heart syndrome: impact of counseling patterns on parental perceptions and decisions regarding termination of pregnancy.

Authors:  Debra Hilton-Kamm; Ruey-Kang Chang; Mark Sklansky
Journal:  Pediatr Cardiol       Date:  2012-05-23       Impact factor: 1.655

4.  Factors influencing parental decisions to terminate pregnancies following prenatal diagnoses of major fetal anomalies at Ramathibodi Hospital, Bangkok, Thailand.

Authors:  Papapin Pusayapaibul; Jittima Manonai; Chayada Tangshewinsirikul
Journal:  BMC Pregnancy Childbirth       Date:  2022-06-13       Impact factor: 3.105

5.  Ethical issues in fetal management: a cardiac perspective.

Authors:  Atul Malhotra; Samuel Menahem; Lynn Gillam
Journal:  Int J Pediatr       Date:  2010-03-24

6.  Chromosomal anomalies influence parental treatment decisions in relation to prenatally diagnosed congenital heart disease.

Authors:  Sinai C Zyblewski; Elizabeth G Hill; Girish Shirali; Andrew Atz; Geoffrey Forbus; Javier Gonzalez; Anthony Hlavacek
Journal:  Pediatr Cardiol       Date:  2009-08-25       Impact factor: 1.655

7.  A population-based study of the association of prenatal diagnosis with survival rate for infants with congenital heart defects.

Authors:  Matthew E Oster; Christopher H Kim; Aaron S Kusano; Janet D Cragan; Paul Dressler; Alice R Hales; William T Mahle; Adolfo Correa
Journal:  Am J Cardiol       Date:  2013-12-27       Impact factor: 2.778

8.  Content and quality of information websites about congenital heart defects following a prenatal diagnosis.

Authors:  Tommy Carlsson; Gunnar Bergman; Anna-Malin Karlsson; Elisabet Mattsson
Journal:  Interact J Med Res       Date:  2015-01-21

9.  Emotional and cognitive experiences during the time of diagnosis and decision-making following a prenatal diagnosis: a qualitative study of males presented with congenital heart defect in the fetus carried by their pregnant partner.

Authors:  Tommy Carlsson; Elisabet Mattsson
Journal:  BMC Pregnancy Childbirth       Date:  2018-01-12       Impact factor: 3.007

10.  Quality of Patient Information Websites About Congenital Heart Defects: Mixed-Methods Study of Perspectives Among Individuals With Experience of a Prenatal Diagnosis.

Authors:  Tommy Carlsson; Ulla Melander Marttala; Barbro Wadensten; Gunnar Bergman; Ove Axelsson; Elisabet Mattsson
Journal:  Interact J Med Res       Date:  2017-09-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.